巨细胞动脉炎患者死亡率升高:一项基于人群的研究
该研究利用加拿大安大略省健康行政数据,纳入22,677例≥50岁巨细胞动脉炎(GCA)患者及同龄一般人群对照,评估2000至2018年全因死亡率。结果显示GCA患者年龄和性别标准化死亡率显著高于一般人群,且随时间呈上升趋势,相对超额死亡未改善。
要点
- GCA患者年龄和性别标准化死亡率显著高于一般人群,且趋势随时间上升。
- GCA患者年度标准化死亡比(SMR)从2002年最低1.22升至2018年最高1.92。
- 男性GCA患者死亡率升高幅度大于女性,年轻年龄组出现过早死亡。
核心结论
- 在19年观察期内,GCA患者死亡率相对于一般人群升高,且相对超额死亡未随时间改善。
研究设计与样本
- 基于加拿大安大略省健康行政数据的人群队列研究,纳入22,677例≥50岁GCA患者(验证病例定义阳性预测值81%、特异性100%)及≥50岁无GCA的一般人群对照。
主要发现
- GCA患者年龄和性别标准化死亡率显著高于对照,2000年为每1,000例GCA患者50.0例死亡(95%CI 34.0-71.1),2018年为57.6例(95%CI 50.8-65.2),而一般人群死亡率显著下降。
- GCA患者年度SMR总体随时间上升,最低为2002年1.22(95%CI 1.03-1.40),最高为2018年1.92(95%CI 1.81-2.03)。
- 男性GCA患者死亡率升高幅度大于女性患者。
临床怎么用
- 临床应认识到GCA患者存在持续升高的超额死亡风险,尤其男性及年轻患者,需加强长期随访与共病管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Reports of mortality risks among individuals with giant cell arteritis (GCA) have been mixed. Our aim was to evaluate all-cause mortality among individuals with GCA relative to the general population over time. METHODS: We performed a population-based study in Ontario, Canada using health administrative data. We studied a cohort of 22,677 GCA patients ages ≥50 years that was identified using a validated case definition (with 81% positive predictive value, 100% specificity). General population comparators were residents ages ≥50 years without GCA. Deaths were ascertained from vital statistics. Annual crude, age- and sex-standardized, and age- and sex-specific all-cause mortality rates were determined for individuals with and without GCA between 2000 and 2018. Standardized mortality ratios (SMRs) were estimated. RESULTS: Age- and sex-standardized mortality rates were significantly higher for GCA patients than comparators, and trending to increase over time with 50.0 deaths per 1,000 GCA patients in 2000 (95% confidence interval [95% CI] 34.0-71.1) and 57.6 deaths per 1,000 GCA patients in 2018 (95% CI 50.8-65.2), whereas mortality rates in the general population significantly declined over time. The annual SMRs for GCA patients generally increased over time, with the lowest SMR occurring in 2002 (1.22 [95% CI 1.03-1.40]) and the highest in 2018 (1.92 [95% CI 1.81-2.03]). GCA mortality rates were more elevated for male patients than female patients. CONCLUSION: Over a 19-year period, mortality rates were increased among GCA patients relative to the general population, and more premature deaths were occurring in younger age groups. The relative excess mortality for GCA patients did not improve over time.
引用
- Barra L, Pope JE, Pequeno P, et al. Increased Mortality for Individuals With Giant Cell Arteritis: A Population-Based Study. Arthritis Care Res (Hoboken). 2022. PMID: 33544963. doi:10.1002/acr.24573
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。